Key TakeawaysUBS upgraded chemicals company Chemours, arguing that the market has been too negative on the stock, which it believes can outperform.The analysts raised their rating to "buy," and increased the price target by $2.UBS said Chemours will benefit from higher profits from colorant titanium dioxide (TiO2) and demand for its next-generation refrigerants. The Chemours Co. (CC) shares gained in intraday trading Tuesday following an upgrade from UBS analysts, who said investors have been too negative o ...